BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-β1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J Gastroenterol 2003; 9(11): 2490-2496 [PMID: 14606082 DOI: 10.3748/wjg.v9.i11.2490]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2490.htm
Number Citing Articles
1
Aiqun Xue, Christopher J. Scarlett, Christopher J. Jackson, Barry J. Allen, Ross C. Smith. Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal AdenocarcinomaPancreas 2008; 36(2): 160 doi: 10.1097/MPA.0b013e31815750f0
2
Xun-ya Hou, Magda K. Ellis, Donald P. McManus, Yuan-yuan Wang, Shang-da Li, Gail M. Williams, Yue-sheng Li. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonicaInternational Journal for Parasitology 2011; 41(3-4): 325 doi: 10.1016/j.ijpara.2010.10.007
3
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosisWorld Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
4
Krystian Adrych, Marian Smoczynski, Magdalena Stojek, Tomasz Sledzinski, Justyna Korczynska, Elzbieta Goyke, Julian Swierczynski. Coordinated Increase in Serum Platelet-Derived Growth Factor-BB and Transforming Growth Factor-β1 in Patients with Chronic PancreatitisPancreatology 2011; 11(4): 434 doi: 10.1159/000330294
5
Qinglin Zhang, Xun Sun, Jianxun Ding, Ping He, Yujia Liu, Hongjing Cheng, Changlin Zhou, Xiangwei Meng. Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured RatsStem Cells International 2015; 2015: 1 doi: 10.1155/2015/459580
6
Zhiyang Chen, Yichen Ma, Jingyao Cai, Mei Sun, Ling Zeng, Fengxi Wu, Yiru Zhang, Min Hu. Serum biomarkers for liver fibrosisClinica Chimica Acta 2022; 537: 16 doi: 10.1016/j.cca.2022.09.022
7
M J Brookes, B T Cooper. Hypertension and fatty liver: guilty by association?Journal of Human Hypertension 2007; 21(4): 264 doi: 10.1038/sj.jhh.1002148
8
Gamal Shiha, Nasser Mousa. Liver Diseases2020; : 427 doi: 10.1007/978-3-030-24432-3_36
9
QIXUAN BAI, JING AN, XIAONING WU, HONG YOU, HONG MA, TIANHUI LIU, NA GAO, JIDONG JIA. HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitroInternational Journal of Molecular Medicine 2012; 30(6): 1443 doi: 10.3892/ijmm.2012.1148
10
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progressionFuture Science OA 2018; 4(1): FSO250 doi: 10.4155/fsoa-2017-0083
11
FANGJU SU, WEIZE ZHANG, YONGQING CHEN, LING MA, HANPING ZHANG, FEI WANG. Significance of hypoxia-inducible factor-1α expression with atrial fibrosis in rats induced with isoproterenolExperimental and Therapeutic Medicine 2014; 8(6): 1677 doi: 10.3892/etm.2014.1989
12
Cai-Feng Chen, Xia Feng, Hui-Yu Liao, Wen-Jing Jin, Jian Zhang, Yu Wang, Lu-Lu Gong, Jing-Jun Liu, Xiao-Hui Yuan, Bin-Bin Zhao, Ding Zhang, Guo-Feng Chen, Ying Wan, Jian Guo, Hui-Ping Yan, You-Wen He. Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infectionScientific Reports 2014; 4(1) doi: 10.1038/srep06359
13
Lu Zhao, Song Wu, Erya Huang, Dimitri Gnatenko, Wadie F. Bahou, Wei Zhu, Geraldo A Passos. Integrated micro/messenger RNA regulatory networks in essential thrombocytosisPLOS ONE 2018; 13(2): e0191932 doi: 10.1371/journal.pone.0191932
14
K. Sri Manjari, Pratibha Nallari, N. Balakrishna, A. Vidyasagar, B. Prabhakar, A. Jyothy, A. Venkateshwari. Influence of Matrix Metalloproteinase-1 Gene −1607 (1G/2G) (rs1799750) Promoter Polymorphism on Circulating Levels of MMP-1 in Chronic PancreatitisBiochemical Genetics 2013; 51(7-8): 644 doi: 10.1007/s10528-013-9594-9
15
Qing-He Nie, Ya-Fei Zhang, Yu-Mei Xie, Xin-Dong Luo, Bin Shao, Jun Li, Yong-Xing Zhou. Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis modelsWorld Journal of Gastroenterology 2006; 12(19): 3044-3049 doi: 10.3748/wjg.v12.i19.3044
16
Junko Hatta, Toshihisa Hatta, Kouzo Moritake, Hiroki Otani. Heavy water inhibiting the expression of transforming growth factor–β1and the development of kaolin-induced hydrocephalus in miceJournal of Neurosurgery: Pediatrics 2006; 104(4): 251 doi: 10.3171/ped.2006.104.4.251
17
Jun Tao, Hui-Qin Peng, Wei-Min Cai, Feng-Qin Dong, Hong-Lei Weng, Rong-Hua Liu. Influence factors of serum fibrosis markers in liver fibrosisWorld Journal of Gastroenterology 2003; 9(11): 2497-2500 doi: 10.3748/wjg.v9.i11.2497
18
Peng Hu, Yuan Han Qin, Juan Pei, Feng Ying Lei, Bo Hu, Ling Lu. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of α-smooth muscle actin: A comparative study between ATRA and benazeprilExperimental and Molecular Pathology 2010; 89(1): 51 doi: 10.1016/j.yexmp.2010.05.003
19
Vanja Ničković, Jelenka Nikolić, Gordana Kocić, Milena Ilić, Boris Djindjić. COMPLICATIONS OF ALCOHOLIC LIVER DISEASE AND DIAGNOSTIC MARKERSActa medica medianae 2011; : 55 doi: 10.5633/amm.2011.0410
20
I Flisiak, H Myśliwiec, B Chodynicka. Effect of psoriasis treatment on plasma concentrations of metalloproteinase‐1 and tissue inhibitor of metalloproteinases‐1Journal of the European Academy of Dermatology and Venereology 2005; 19(4): 418 doi: 10.1111/j.1468-3083.2005.01199.x
21
Guilian Sun, Kazuhiro Haginoya, Yoko Chiba, Mitsugu Uematsu, Naomi Hino-Fukuyo, Soichiro Tanaka, Akira Onuma, Kazuie Iinuma, Shigeru Tsuchiya. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophyJournal of the Neurological Sciences 2010; 297(1-2): 19 doi: 10.1016/j.jns.2010.06.031
22
Robert Flisiak, Jerzy Jaroszewicz, Tadeusz W. Łapiński, Iwona Flisiak, Magdalena Rogalska, Danuta Prokopowicz. Plasma transforming growth factor β1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type BRegulatory Peptides 2005; 131(1-3): 54 doi: 10.1016/j.regpep.2005.06.002
23
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
24
Li-Juan Zhang, Yun-Xin Chen, Zhi-Xin Chen, Yue-Hong Huang, Jie-Ping Yu, Xiao-Zhong Wang. Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cellsWorld Journal of Gastroenterology 2004; 10(17): 2574-2579 doi: 10.3748/wjg.v10.i17.2574
25
Ekhlas H. Abdel-Hafeez, Azza K. Ahmad, Ahlam M. Abdulla, Soha Aabdel-Wahab, Fadia A. Mosalem. Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged miceParasitology Research 2012; 111(2): 577 doi: 10.1007/s00436-012-2871-4
26
Maha M. Arafah, Mohammad M. Al-Qattan, Durria A. Abdulmaged-Ahmed, Ghada A. Al-Nafesah, Nessrin Y. Jadu, Reginald S. Bagayawa, Medhat K. Shier, Amir Marzouk, Hend S. Almalki. The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis ModelBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/9846919
27
Koji Miyahara, Kazuhiro Nouso, Takeshi Tomoda, Sayo Kobayashi, Hiroaki Hagihara, Kenji Kuwaki, Junichi Toshimori, Hideki Onishi, Fusao Ikeda, Yasuhiro Miyake, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Kazuhide Yamamoto. Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2011; 26(11): 1604 doi: 10.1111/j.1440-1746.2011.06887.x
28
Dariusz Marek Lebensztejn, Elżbieta Skiba, Jolanta Tobolczyk, Maria Elżbieta Sobaniec-Lotowska, Maciej Kaczmarski. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysisWorld Journal of Gastroenterology 2005; 11(45): 7192-7196 doi: 10.3748/wjg.v11.i45.7192
29
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver FibrosisBiomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
30
Rebecca Mercedes, Jameisha Brown, Charles Minard, Cynthia M. Tsai, Sridevi Devaraj, Marthe Munden, Daniel Leung. A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral HepatitisGlobal Pediatric Health 2020; 7: 2333794X2093893 doi: 10.1177/2333794X20938931
31
Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad T Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid, Sajida Hassan. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluationVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-53
32
Monica L. Brown Lobbins, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Robert C. Tuckey, Imara-Safi O. Scott, Linda K. Myers, Arnold E. Postlethwaite. Modulation by 17,20S(OH)2pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic SclerosisInternational Journal of Molecular Sciences 2021; 23(1): 367 doi: 10.3390/ijms23010367
33
Ruslan Novosyadlyy, Jozsef Dudas, Rajeswararao Pannem, Giuliano Ramadori, Jens-Gerd Scharf. Crosstalk between PDGF and IGF-I receptors in rat liver myofibroblasts: implication for liver fibrogenesisLaboratory Investigation 2006; 86(7): 710 doi: 10.1038/labinvest.3700426
34
Seyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewClinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(5): 577 doi: 10.1515/cclm-2018-0357
35
Zohar Pode, Ronny Peri-Naor, Joseph M. Georgeson, Tal Ilani, Vladimir Kiss, Tamar Unger, Barak Markus, Haim M. Barr, Leila Motiei, David Margulies. Protein recognition by a pattern-generating fluorescent molecular probeNature Nanotechnology 2017; 12(12): 1161 doi: 10.1038/nnano.2017.175
36
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An OverviewAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
37
Melissa A. Sheiko, Hugo R. Rosen. Hepatitis C Virus II2016; : 79 doi: 10.1007/978-4-431-56101-9_3
38
Caroline Lefeuvre, Marine Roux, Simon Blanchard, Hélène Le Guillou-Guillemette, Jérôme Boursier, Françoise Lunel-Fabiani, Pascale Jeannin, Adeline Pivert, Alexandra Ducancelle. Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutantsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14285-9
39
Ahmed S. Abedel Haleem, Laila N. Mohamed, Eman A. Elgohary. Role of fibroscan, TGF-β1, and YKL-40 in the detection of hepatic fibrosis in chronic hepatitis c patients with and without schistosomiasisEgyptian Liver Journal 2015; 5(3): 47 doi: 10.1097/01.ELX.0000480459.86809.74
40
Silja H. Voutilainen, Silja K. Kosola, Taina I. Tervahartiala, Timo A. Sorsa, Hannu J. Jalanko, Mikko P. Pakarinen. Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipientsTransplant International 2017; 30(2): 124 doi: 10.1111/tri.12879
41
Mirhan N. Makled, Maha H. Sharawy, Mohammed S. El-Awady. The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptinNaunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(12): 1569 doi: 10.1007/s00210-019-01703-5
42
HONG-HUI SHEN, BING-KE BAI, YA-QING WANG, GUANG-DE ZHOU, JUN HOU, YAN HU, JING-MIN ZHAO, BAO-SEN LI, HAI-LI HUANG, PAN-YONG MAO. Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis BExperimental and Therapeutic Medicine 2015; 9(3): 999 doi: 10.3892/etm.2015.2182
43
Yasuko Hasegawa-Baba, Kunio Doi. Changes in TIMP-1 and -2 expression in the early stage of porcine serum-induced liver fibrosis in ratsExperimental and Toxicologic Pathology 2011; 63(4): 357 doi: 10.1016/j.etp.2010.02.011
44
Maha H. Sharawy, Mohammed S. El‐Awady, Mirhan N. Makled. Protective effects of paclitaxel on thioacetamide‐induced liver fibrosis in a rat modelJournal of Biochemical and Molecular Toxicology 2021; 35(5) doi: 10.1002/jbt.22745
45
Arnaud Carpentier, Filoména Conti, Matthieu Carrière, Lynda Aoudjehane, Céline Miroux, Olivier Moralès, Yvon Calmus, Hervé Groux, Claude Auriault, Véronique Pancré, Nadira Delhem, Philippe Podevin. Analysis of gene transcription in sera during chronic hepatitis C infectionJournal of Medical Virology 2009; 81(3): 473 doi: 10.1002/jmv.21398
46
Doreen Reichert, Louisa Adolph, Jan Philipp Köhler, Tobias Buschmann, Tom Luedde, Dieter Häussinger, Claus Kordes. Improved Recovery from Liver Fibrosis by CrenolanibCells 2021; 10(4): 804 doi: 10.3390/cells10040804
47
Mark A. Feitelson, Helena M.G.P.V. Reis, N. Lale Tufan, Bill Sun, Jingbo Pan, Zhaorui Lian. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver diseaseCancer Letters 2009; 286(1): 69 doi: 10.1016/j.canlet.2008.12.010
48
Vanja Ničković, Jelenka Nikolić, Gordana Kocić, Milena Ilić, Boris Đinđić. KOMPLIKACIJE ALKOHOLNE BOLESTI JETRE I DIJAGNOSTIČKI MARKERIActa medica medianae 2011; : 55 doi: 10.5633/amm.2011.0410s
49
Yoav Lurie, Muriel Webb, Ruth Cytter-Kuint, Shimon Shteingart, Gerardo Z Lederkremer. Non-invasive diagnosis of liver fibrosis and cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11567-11583 doi: 10.3748/wjg.v21.i41.11567
50
C Martín-González, L González-Navarrete, I Ribot-Hernández, V Vera-Delgado, J Alvisa-Negrín, A Godoy-Reyes, E Espelosín-Ortega, P Abreu-González, E González-Reimers. Platelet-Derived Growth Factor C in AlcoholicsAlcohol and Alcoholism 2020; 55(2): 157 doi: 10.1093/alcalc/agz094